Companies: 10,795·Total market cap: $144.5T
Purple Biotech Ltd.

Purple Biotech Ltd.

PPBTNASDAQHealthcare● Active
$2.92
$-0.05(-1.68%)
Market Cap$403205
P/E Ratio—
52W High$29
52W Low$2.52
Overview
Foreign Private Issuer · Files 20-F / 6-K

Purple Biotech Ltd. (PPBT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001614744 · PPBT · NASDAQ · as of Jun 8, 2026

Filing snapshot

567
Total Filings
F-3
Latest Form
2026-05-20
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001614744 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-19
Fiscal Year End
Mar 19, 2026
Accession No.
0001213900-26-031365
Primary Document
ea0281765-20f_purple.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001614744 · Accession 0001213900-26-031365

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-15
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
F-3F-3
REGISTRATION STATEMENT
2026-05-20
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-17
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-07
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-06
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-31
View
3/AInitial Statement of Beneficial Ownership (Amended)
Initial Statement of Beneficial Ownership (Amended)
2026-03-30
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-30
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-25
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-19
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-03-19
View
Showing 1–15 of 567 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001614744  |  Exchange: NASDAQ · Healthcare

Purple Biotech Ltd. (NASDAQ: PPBT) has submitted 567 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001614744, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Purple Biotech Ltd.'s most comprehensive regulatory disclosure. The most recent Purple Biotech Ltd. 10-K was filed on 2026-03-19 for fiscal year ending 2026. Historical PPBT 10-K annual reports are available from 2014 through 2026.

Investors researching Purple Biotech Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
AKTX SEC Filings →REVB SEC Filings →CDT SEC Filings →DRMA SEC Filings →XAGE SEC Filings →MSPR SEC Filings →VINC SEC Filings →PBM SEC Filings →
→ PPBT Financials→ PPBT Earnings→ PPBT Insider Trades

Frequently Asked Questions

PPBT SEC Filings · 8 questions

Purple Biotech Ltd. (PPBT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 567 filings and access original documents at no cost. Purple Biotech Ltd.'s CIK is 0001614744.

PPBT SEC filingsPurple Biotech Ltd. SEC documentsfind PPBT 10-K